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Featured Article
In this month’s newsletter, Associate
Professor Dr Tay Pek San discusses the remit
of the Telemedicine Act 1997 and the legal
challenges in implementing telemedicine in
Malaysia.
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News
Congratulations to our members on the
following publications:
Articles
Ainee Adam (2020). Pricing and
proofing in copyright: introducing an
Islamic perspective. Queen Mary Journal of
Intellectual Property, vol 10, issue 2.
Sharon Kaur Gurmukh Singh. Peer Review
Report For: Social, ethical and
behavioural aspects of COVID-19 [version 1;
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28 May 2020
Events
Sharon Kaur Gurmukh Singh spoke at the
expert seminar on "Human Rights and
Authoritarianism in the time of Covid-19"
organised by SHAPE SEA (Strengthening
Human Rights and Peace Research and
Education in ASEAN/Southeast Asia).
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Appointments
Mohammad Ershadul Karim.  Appointed as
Member of the Technical Advisory
Committee, 1st International Conference of
Advanced Research on Renewable Energy
for Universal Sustainability 2021 (27-28
March 2021), Arus Infiniti Sdn Bhd and
Razak Faculty of Technology and
Informatics, Universiti Teknologi Malaysia,
Malaysia.
Sharon Kaur Gurmukh Singh. Appointed as
Member of the Planning Committee of  the
Global Forum for Bioethics in Research
2020.
Sharon Kaur Gurmukh Singh. Appointed as
Member of the Data Sharing Working Group
for the COVID-19 Clinical Research
Coalition (https://covid19crc.org).
Sik Cheng Peng. Appointed as Member of
the Policy Working Group on Malaysia Open
Science Platform by Malaysian Open
Science Alliance.
Embracing Telemedicine in the New Normal: 
The Legal Challenges
By Associate Professor Dr Tay Pek San
Faculty of Law, University of Malaya
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Introduction 
The Covid-19 pandemic has forced us to limit
face-to-face interaction with others as a way of
curbing the spread of the disease. This has
brought telemedicine into a new light. In the
current pandemic situation, the healthcare
system is faced with the need to provide
continued medical care for patients and to
ensure that the patients’ risk of exposure to the
coronavirus is minimized. The difficulty is more
acute for public hospitals which are Covid-19
centres. Frontline healthcare workers put their
lives at risk every day because of physical
contact with affected patients. In view of the
risks of transmission and depending on the
circumstances they are in, they might need to
shift from their usual method of delivering
medical care.
These hospitals face the dilemma on how to
sustain the capacity to provide medical
care to Covid-19 and other non-communicable
disease patients. Some of these hospitals have
to reschedule medical appointments with
their patients to a later date. While this may be
acceptable in respect of routine or elective
medical appointments, the same cannot be
said for patients suffering from life-threatening
diseases, such as heart attack, stroke, diabetes,
cancer and the like.
Telemedicine is an ideal way of bridging the
gap for patients to have access to their doctors
in the comfort of their homes and minimize
their risk of infection. As with many other
technology-driven innovations, the legal and
regulatory response to the implementation of
telemedicine is slower than its clinical
adoption.
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Currently, there is no law that is in force in our
country which regulates telemedicine in the
healthcare industry. Understandably, there
are also no local court decisions on
telemedicine to serve as legal precedents to
guide its adoption and development. The
Telemedicine Act 1997, which was enacted to
provide for the regulation and control of the
practice of telemedicine, has not been
enforced despite being more than two
decades old.
The absence of a legal framework that
regulates telemedicine represents a major
challenge to its widespread adoption. Given
this legal vacuum, the Malaysian Medical
Council has recently issued an advisory on
virtual consultation that is applicable during
the Covid-19 pandemic. [1] 
The advisory covers a range of matters which
doctors must follow, exercise or ensure when
adopting telemedicine. It also states that a
doctor can only have virtual consultation with
a person who is already his patient. In other
words, telemedicine is to be used only as a
continuation of care or follow-up and not for
diagnosis or treatment purposes.
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Frontline healthcare workers put their lives at risk
every day because of physical contact with affected
patients. In view of the risks of transmission and
depending on the circumstances they are in...
Telemedicine is an ideal way of bridging the gap for
patients to have access to their doctors in the
comfort of their homes and minimize their risk of
infection.
A doctor who is registered outside
Malaysia and holds a certificate to practise
telemedicine issued by the Malaysian
Medical Council.  In addition, the doctor
must practise telemedicine from outside
Malaysia through a fully registered doctor
holding a valid practising certificate under
the Medical Act 1971
A provisionally registered doctor, a
registered medical assistant, a registered
nurse, a registered midwife or any person
providing healthcare who works under the
supervision, control and authority of a fully
registered doctor and is permitted by the
Director-General of Health, Malaysia to
practise telemedicine
He is free to withdraw his consent at any
time without affecting his right to future
care or treatment
He knows of the potential risks,
consequences and benefits of
telemedicine
Individuals who practise telemedicine but do
not fall within any of the above categories
commit an offence, which is punishable with
a fine and/or imprisonment.
The second aspect deals with the patient’s
consent to the use of telemedicine. A doctor
is required to obtain the written consent of his
patient before practising telemedicine in
relation to him. [3] To constitute a valid
consent, the Act requires the doctor to first
inform the patient of several matters. These
are:
·        
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The Telemedicine Act 1997 covers two important
aspects of telemedicine. The first deals with the
categories of individuals who are permitted to
practise telemedicine in Malaysia...The second
aspect deals with the patient’s consent to the use
of telemedicine.
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A fully registered doctor under the
Medical Act 1971 holding a valid practising
certificate
This note provides an overview of the major
legal challenges of telemedicine. One of the
most significant legal challenges is the
protection of patients’ privacy and
confidentiality in the digital environment. 
This was aptly dealt with in the previous issue
of this newsletter (CELEST Newsletter, May
2020 Issue 2) by Dr Mohammad Firdaus
Abdul Aziz and, hence, will not be revisited
here. 
This note focuses on patients’ informed
consent, liability for telemedicine
malpractice, insurance, and cross-border
practice of telemedicine. Before addressing
these issues, this note will discuss the scope of
the Telemedicine Act 1997 in order to
acquaint readers with Parliament’s stance on
telemedicine during its enactment in 1997.
Telemedicine Act 1997
The Telemedicine Act 1997 covers two
important aspects of telemedicine. The first
deals with the categories of individuals who
are permitted to practise telemedicine in
Malaysia. The categories are: [2]
·        
He is aware that all existing confidentiality
protection apply to any information about
him which is obtained or disclosed in the
course of the telemedicine interaction
He understands that any image or
information resulting from the
telemedicine interaction will not be
disseminated to any person without his
consent
The written consent must contain a
statement signed by the patient
indicating that he understands the
information provided above and that he has
discussed that information with his doctor.
These will become part of the patient’s
medical records. The failure by the doctor to
obtain the patient’s written consent or to
inform him of the above matters before
obtaining his consent is an offence.
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Legal challenges of telemedicine
Informed consent
The doctrine of informed consent requires
doctors to provide their patients with
sufficient information so that the patients
can assent to or withhold consent from a
medical treatment. A patient needs to be
informed of telemedicine’s risks, benefits
and limitations. 
Thus, a doctor should discuss with his
patient the risks or limitations affecting
medical examination and, consequently,
medical advice. It is also important to notify
the patient of technical risks associated with
electronic transmissions that could cause
distortions in images, unauthorized
interception of electronic communications
or illegal access to the patient’s electronic
medical records. [4]
Where the doctor intends to audio
or video record  the consultation, he
should inform the patient and seek his
consent. Other matters which a doctor
needs to discuss with his patients are spelt
out in the Telemedicine Act 1997
and have been noted above. 
The Act requires that the consent from the
patient be in a written form. It also requires
that the consent be accompanied by a
signed statement from the patient stating
that he understands the information which
the doctor discussed with him.
The doctrine of informed consent requires doctors to
provide their patients with sufficient information so that
the patients can assent to or withhold consent from a
medical treatment...Other matters which a doctor
needs to discuss with his patients are spelt out in the
Telemedicine Act 1997...
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The Act confers on the Minister the power to
make regulations on a wide range of matters.
These include prescribing the minimum
standards of any facilities used in
telemedicine and providing for acceptable
quality assurance and quality control in
respect of telemedicine services.
The consent to participate in telemedicine
extends only to the doctor attending to the
patient and any assistants deemed
necessary for the consultation. [5] Thus,
specific consent will have to be obtained
from the patient if there are others
present during the consultation. This may
mean that in public hospitals where
different junior doctors under the
supervision of a senior doctor attend to
patients on different occasions, a separate
written consent is needed for each
telemedicine consultation. This obviously
creates a ridiculous situation where the
patient has to be physically present to give
a written consent on each occasion, in
which case the patient would be better off
seeing the junior doctor face-to-face. It is
suggested that the written consent which
is obtained by the senior doctor on the first
occasion should be widely-framed to
include future attendance by junior doctors
under that senior doctor’s supervision.
However, this situation does not arise in
private hospitals where a patient is
attended to solely by one doctor.
While it cannot be denied that the gold
standard is to obtain a written consent
from patients specifically for telemedicine,
the exigencies of particular situations may
necessitate a relaxation of the requirement
for patients’ written consent. This is
particularly so since the Telemedicine Act
1997 has not yet come into force and, in the
absence of a legislative mandate, there is
currently no law in this country that
demands that written consent must be
obtained from patients to participate in
telemedicine.
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While it cannot be denied that the gold standard is to
obtain a written consent from patients specifically for
telemedicine, the exigencies of particular situations
may necessitate a relaxation of the requirement for
patients’ written consent.
For instance, the Covid-19 emergency that
has befallen the country within a matter of
weeks has left little or no time for many
public hospitals to obtain the prior written
consent of their existing patients to the use
of telemedicine. Several Covid-19 designated
hospitals have temporarily suspended
outpatient clinics and are out of bounds for
most non-Covid-19 patients. For these
hospitals, there is no possibility for their
existing patients to go to the hospitals to
sign any written consent. Yet, some of these
patients need close medical attention. 
During this emergency, it is suggested that a
modified form of consent be considered
instead. An electronic consent, such as
through e-mails or WhatsApp messages, or
even a recorded verbal consent is arguably
sufficient. This is a temporary response
during the duration of the emergency and
not a permanent policy shift away from a
written consent.
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According to the test, the doctor is required
to act in accordance with ‘a practice
accepted as proper by a responsible body of
medical men skilled in that medical act’. In
other words, the courts need to rely on the
expert opinions of medical practitioners to
determine whether negligence has
occurred. However, in 2007, our
Federal Court departed from the Bolam test
in Foo Fio Na v Dr Soo Fook Mun & Anor. [9]
The court decided that the Bolam test has
no relevance to the duty and standard of
care in providing advice to a patient.  
Instead, the court adopted the test in the
Australian case of Rogers v Whitaker. [10] 
In that case, the Australian High Court made
a distinction between, on the one hand, the
doctor’s duty of treatment and diagnosis
and, on the other hand, the duty to advise of
material risks. In Zulhasnimar Hasan Basri v
Dr Kuppu Velumani P, [11] the Federal Court
further provided a clearer legal position with
regard to the distinction. In the context of
diagnosis and treatment, the Bolam test will
apply since  the courts are not equipped
with the expertise and skills to decide
whether there is negligence in the matter.
However, as patients have the right of self-
determination, the court will decide whether
a patient has been properly advised before
consent is obtained from the patient.
In situations where telemedicine practice is
less effective than the traditional mode of
healthcare delivery, such as where full
medical examination or touch cannot be
carried out, questions arise as to how
this may affect the standard of care. The
challenges faced by doctors in observing the  
informed consent requirement and how
these would affect their duty to advise of
material risks are unclear.
Malpractice
The elements of negligence in the traditional
mode of healthcare delivery, namely, duty of
care owed by the doctor to the patient,
breach of that duty of care and causation or
consequential damage to the patient, are
equally relevant in telemedicine
malpractice. [6]
Unlike the traditional setting where the
doctor and patient are in the same
consultation room, the inherent feature of
telemedicine is that both parties are
separated by distance. This would usually
not create added difficulties in
establishing a doctor-patient relationship
except in the case of cross-border
telemedicine. 
Under the Telemedicine Act 1997, cross-
border telemedicine can only be carried out
through a local registered doctor. On the
assumption that this remains the position
when a legislative telemedicine framework is
eventually enforced, it is foreseeable that
difficulties could arise in determining who
the parties are in the doctor-patient
relationship.
In so far as the standard of care is concerned,
questions arise as to the requisite standard
of care in telemedicine. Where the
telemedicine procedures are identical to the
traditional procedures, such as a
telemedicine practitioner reading an X-ray,
the standard of care should be the same. [7]
Prior to 2007, the doctor’s standard of care
in relation to his patient was governed by
the Bolam test that was laid down in the
English case of  Bolam v Friern Hospital
Management Committee. [8]
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Cross-border liability
While national boundaries do not per se
pose any obstacle in the world of
telemedicine, jurisdictional issues will
inevitably arise where there is telemedicine
malpractice. This is because cross-border
telemedicine services span across different
jurisdictions. 
In malpractice cases, it is necessary to
ascertain where the practice of medicine
occurred, which country’s laws apply and
which court has jurisdiction to hear the
dispute. Additional complexity can arise
where countries have differing standards
and requirements of medical care. Such
uncertainties call for legal uniformity
in addressing international telemedicine
disputes. [12]
Insurance
Combining rapidly changing
communications technology with the
complexities of healthcare delivery carries
with it the possibility of new or increased
risks of medical malpractice. Doctors need
to ensure that their professional indemnity
insurance extend to cover healthcare
services rendered through telemedicine. 
Currently, there is no set standard for private
health insurance providers regarding
telemedicine and thus, it behooves doctors
to discuss this with their insurance providers.
Alternatively, the medical industry could
pursue this with the relevant medical
indemnity provider.
NEWSLETTER
Conclusion
Telemedicine is a step forward in our
healthcare system as underscored by the
Covid-19 pandemic. However, its
development depends on the existence of a
suitable regulatory framework that provides
certainty to all stakeholders involved in this
mode of healthcare delivery. The absence of
such regulatory framework in our country
necessitates urgent action to be taken by
the relevant authorities.
...it is foreseeable that difficulties could arise in
determining who the parties are in the doctor-patient
relationship. In so far as the standard of care is
concerned, questions arise as to the requisite standard
of care in telemedicine...
Additional complexity can arise where countries have
differing standards and requirements of medical care.
Such uncertainties call for legal uniformity in addressing
international telemedicine disputes.
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